Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach

SIMPLE SUMMARY: The current study based on virtual drugs screening and simulations identified novel drugs to target the RBD of the spike protein from Omicron variant of SARS-CoV-2. Using molecular modeling tools to search for a good binding drugs we identified SANC00944, SANC01032, SANC00992, and SA...

Descripción completa

Detalles Bibliográficos
Autor principal: Hakami, Abdulrahim R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869371/
https://www.ncbi.nlm.nih.gov/pubmed/35205124
http://dx.doi.org/10.3390/biology11020258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869371/
https://www.ncbi.nlm.nih.gov/pubmed/35205124
http://dx.doi.org/10.3390/biology11020258

Ejemplares similares